Oil Prices Mixed; Looming OPEC+ Production Increase May Weigh
0031 GMT — Oil prices are mixed in the early Asian session, but may be weighed by looming OPEC+ production increase. OPEC+ has announced that it would gradually reduce its voluntary production cuts from this week, Commerzbank Research analysts say in a recent research report. This 'de facto' increase in oil supply will probably take center stage this week and weigh on oil prices, even though there have been worries over future supply shortage, the analysts add. Front-month WTI crude oil futures are down 0.3% at $69.13/bbl; front-month Brent crude oil futures are up 0.1% at $73.71/bbl. (ronnie.harui@wsj.com)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Ether, Dogecoin Surge, Outpaces Bitcoin as DeFi Comments Spurs Bullish Mood
Bitcoin BTC stayed steady above $109,500 in Asian morning hours Wednesday, a rebound that started after last week's profit-taking. However, all eyes are on ether ETH with traders commenting on upside volatility in the weeks to come and reporting record volumes for certain ETH-based products on some exchanges. ETH zoomed 5% in the past 24 hours, leading gains among majors. 'Investors are finally recognizing the compelling investment opportunity that Ethereum presents. It's still trading well below its all-time highs, while bitcoin is already near its ATH levels,' said Jeff Mei, COO at BTSE, in a message to CoinDesk. He pointed to Ethereum's growing role in tokenizing real-world assets like stocks, money-market funds, and U.S. Treasuries, adding that it was 'very likely that Ethereum will reach and/or surpass its all-time high price by the end of the year.' Ether ETFs have attracted more than $800 million in the past two weeks alone, outpacing bitcoin's sub-$400 million, according to SoSoValue data. That's helped the spread between ether's implied volatility and bitcoin's reach its highest level since late 2022 — a sign traders expect bigger price swings ahead. Open interest in ether perpetuals on Kraken hit an all-time high of 30,000 ETH this week, said Alexia Theodorou, Head of Derivatives at Kraken, in an email to CoinDesk. 'This signals a notable uptick in speculative activity around the second-largest cryptocurrency by market cap,' she noted. However, she cautioned that the market 'has yet to form a clear directional consensus,' with the long/short ratio still well below January levels. Elsewhere in the market, Solana SOL and Cardano ADA posted gains of 4.7% and 3.3%, respectively, adding to the risk-on tone, while XRP XRP rose 2% to $2.30. Ethereum beta bet dogecoin DOGE climbed 3.7% to reverse all of last week's losses. Traders are closely watching upcoming U.S. CPI data on Wednesday, which could sway Federal Reserve rate expectations and shape risk sentiment ahead of next week's meeting.
Yahoo
23 minutes ago
- Yahoo
Türkiye competition watchdog to probe Coca-Cola İçecek
An investigation has been launched into Türkiye's Coca-Cola İçecek regarding a potential breach of the country's competition laws. The country's competition authority Rekabet Kurumu said yesterday (10 June) Coca-Cola İçecek's subsidiary Coca-Cola Satış ve Dağıtım (Sales and Distribution) was the subject of its probe. The investigation is to assess whether the group has "violated" the competition protection law Act no. 4054, by "imposing exclusivity on retail outlets and excluding competitors from outlets". Shares in Coca-Cola İçecek were down 2.47% to Tl51.30 ($1.31) around noon GMT today, following the announcement. The decision to investigate Coca-Cola İçecek's Coca-Cola Satış ve Dağıtım followed a preliminary inquiry in March. In a statement, Coca-Cola İçecek stressed the launch of the probe "does not necessarily mean that the company subject to investigation has actually violated The Act on the Protection of Competition No.4054 nor it will be subject to a penalty due to a violation of the Competition Law regulations". The Cola-Cola Satış ve Dağıtım business was already investigated by Rekabet Kurumu in 2021 for "preventing the sale of rival products at final sale points". In 2022, the competition authority accepted a "commitment package" from the business which looked to fix the competition issues. These pledges included offering discounts and promotions at sales points only to the same types of beverages. In its guidance for 2025 published in March, Coca-Cola İçecek said the group expected to be "cycling a difficult operating environment in 2024". It added: "We will focus on driving volume growth by prioritising affordability for consumers." For 2025, Coca-Cola İçecek anticipates "low to mid-single-digit growth" in sales volumes in Türkiye and "mid-to high-single-digit growth" for volumes its other global markets. The company also expects to see a "flat EBIT margin", accounting for inflation. In 2024, Coca-Cola İçecek's international volumes declined the most, by 3.6% to 934 million unit cases, attributed to "weakened volume momentum in Pakistan". Volumes in Türkiye stayed flat at 568 million unit cases. Consolidated volumes declined 2.2% to 1.5 billion unit cases. "Türkiye competition watchdog to probe Coca-Cola İçecek" was originally created and published by Just Drinks, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
an hour ago
- Associated Press
Protein Drugs Analysis Report 2025: Market to Reach $655.7 Billion by 2029 from $441.7 Billion in 2024, Fueled by Increasing Number of Approvals for MAbs and Licensing and Collaboration Agreements
DUBLIN--(BUSINESS WIRE)--Jun 11, 2025-- The 'Protein Drugs Market 2025" report has been added to offering. The Protein Drugs Market was valued at USD 441.7 Billion in 2024, and is projected to reach USD 655.7 Billion by 2029, rising at a CAGR of 8.2% The report analyzes trends in the global market for protein drugs and manufacturing technologies. The report includes global revenue ($ millions) for the base year of 2023 and estimated data for the forecast period of 2024 through 2029. The market is segmented by product type/subtype, manufacturing technology and region. The regions covered are North America, Europe, Asia-Pacific and the Rest of the World, focusing on major countries in these regions. Therapeutic proteins are a class of medicines that help treat a number of indications, such as cancer, diabetes, stroke, anemia and hemophilia. Protein drugs perform particular and complex functions compared to small molecules. Due to the high specificity, these protein drugs are less toxic and less likely to interfere with normal biological processes. Protein drugs can be manufactured in many ways, but most proteins are produced through recombinant deoxyribonucleic acid (rDNA) technology, using bacteria, yeast or mammalian cells as the host system. The report focuses on the trends and challenges that affect the market and the vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market. The report concludes with an analysis of the competitive landscape, which provides the rankings and market shares of leading companies in the protein drug market. It also has a section of company profiles that shows financials, product portfolios and recent developments. The report includes: Key Attributes: Key Topics Covered: Chapter 1 Executive Summary Chapter 2 Market Overview Chapter 3 Market Dynamics Chapter 4 Regulatory Landscape Chapter 5 Emerging Technologies Chapter 6 Market Segment Analysis Chapter 7 Competitive Intelligence Chapter 8 Sustainability in the Protein Drug Market: ESG Perspective Companies Featured For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: DIABETES PHARMACEUTICAL HEALTH ONCOLOGY SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 06/11/2025 07:55 AM/DISC: 06/11/2025 07:53 AM
